1. Home
  2. BHVN vs STNE Comparison

BHVN vs STNE Comparison

Compare BHVN & STNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • STNE
  • Stock Information
  • Founded
  • BHVN 2013
  • STNE 2012
  • Country
  • BHVN United States
  • STNE Cayman Islands
  • Employees
  • BHVN N/A
  • STNE N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • STNE EDP Services
  • Sector
  • BHVN Health Care
  • STNE Technology
  • Exchange
  • BHVN Nasdaq
  • STNE Nasdaq
  • Market Cap
  • BHVN 3.6B
  • STNE 3.5B
  • IPO Year
  • BHVN 2017
  • STNE 2018
  • Fundamental
  • Price
  • BHVN $39.17
  • STNE $8.73
  • Analyst Decision
  • BHVN Strong Buy
  • STNE Buy
  • Analyst Count
  • BHVN 13
  • STNE 10
  • Target Price
  • BHVN $63.00
  • STNE $16.10
  • AVG Volume (30 Days)
  • BHVN 1.2M
  • STNE 4.8M
  • Earning Date
  • BHVN 02-27-2025
  • STNE 11-12-2024
  • Dividend Yield
  • BHVN N/A
  • STNE N/A
  • EPS Growth
  • BHVN N/A
  • STNE 103.39
  • EPS
  • BHVN N/A
  • STNE 1.18
  • Revenue
  • BHVN N/A
  • STNE $2,267,378,982.00
  • Revenue This Year
  • BHVN N/A
  • STNE $19.86
  • Revenue Next Year
  • BHVN $197.13
  • STNE $11.63
  • P/E Ratio
  • BHVN N/A
  • STNE $7.25
  • Revenue Growth
  • BHVN N/A
  • STNE 13.89
  • 52 Week Low
  • BHVN $26.80
  • STNE $7.72
  • 52 Week High
  • BHVN $62.21
  • STNE $19.46
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 51.03
  • STNE 53.19
  • Support Level
  • BHVN $35.01
  • STNE $8.38
  • Resistance Level
  • BHVN $39.36
  • STNE $8.83
  • Average True Range (ATR)
  • BHVN 2.07
  • STNE 0.28
  • MACD
  • BHVN 0.50
  • STNE 0.14
  • Stochastic Oscillator
  • BHVN 77.83
  • STNE 90.99

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs great solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services offers payments, digital banking, and credit solutions, focusing Ton solution mainly on micro-merchants, and Stone solution on SMBs. In Software, it offers POS and ERP solutions for different retail and services verticals, Customer Relationship Management, engagement tools, e-commerce, and Order Management System solutions, among others.

Share on Social Networks: